We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $1B
1-Year Est. Return 50.12%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+50.12%
3 Year Est. Return
+144.24%
5 Year Est. Return
+295.18%
10 Year Est. Return
+886.87%
AUM
$1.25B
AUM Growth
-$22.5M
Cap. Flow
-$64.1M
Cap. Flow %
-5.13%
Top 10 Hldgs %
36.19%
Holding
463
New
112
Increased
98
Reduced
115
Closed
63

Top Buys

Rank Stock Value
1
OVV icon
Ovintiv
OVV
+$27.3M
2
AR icon
Antero Resources
AR
+$14.4M
3
HD icon
Home Depot
HD
+$9.11M
4
FOXA icon
Fox Class A
FOXA
+$8.62M
5
DAC icon
Danaos Corp
DAC
+$5.53M

Top Sells

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$59.4M
2
CTRA
Coterra Energy
CTRA
+$20.4M
3
DVN icon
Devon Energy
DVN
+$19.7M
4
ING icon
ING
ING
+$19M
5
STLA icon
Stellantis
STLA
+$12.4M

Sector Composition

Rank Sector Weight
1 Energy 33.98%
2 Technology 11.41%
3 Healthcare 10.88%
4 Industrials 9.96%
5 Consumer Discretionary 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEN
1
DELISTED
Denbury Inc.
DEN
$109M 8.75%
1,390,906
-31,530
-2% -$2.33M
SM icon
2
SM Energy
SM
$7.71B
$69.7M 5.59%
1,790,411
+94,867
+6% +$3.42M
AR icon
3
Antero Resources
AR
$11.5B
$68M 5.45%
2,228,127
+640,925
+40% +$14.4M
DVN icon
4
Devon Energy
DVN
$48.8B
$44.8M 3.59%
757,605
-363,721
-32% -$19.7M
OVV icon
5
Ovintiv
OVV
$17.5B
$34.2M 2.74%
+633,386
New +$27.3M
ABBV icon
6
AbbVie
ABBV
$440B
$28.5M 2.28%
175,689
-8,839
-5% -$1.28M
ACN icon
7
Accenture
ACN
$109B
$26.1M 2.09%
77,519
-1,613
-2% -$544K
FOXA icon
8
Fox Class A
FOXA
$27.5B
$24.9M 1.99%
630,378
+212,345
+51% +$8.62M
CTRA
9
DELISTED
Coterra Energy
CTRA
$24M 1.92%
889,357
-872,723
-50% -$20.4M
RS icon
10
Reliance Steel & Aluminium
RS
$21.7B
$22.2M 1.78%
121,269
-6,095
-5% -$1.05M
FANG icon
11
Diamondback Energy
FANG
$55.9B
$21.9M 1.76%
160,122
+32,590
+26% +$4.24M
PFE icon
12
Pfizer
PFE
$153B
$21.8M 1.75%
420,841
-30,795
-7% -$1.6M
EPSN icon
13
Epsilon Energy
EPSN
$161M
$20.4M 1.64%
3,168,133
HD icon
14
Home Depot
HD
$341B
$20.1M 1.61%
67,138
+26,269
+64% +$9.11M
VVV icon
15
Valvoline
VVV
$4.25B
$20.1M 1.61%
636,583
+43,654
+7% +$1.43M
HUBB icon
16
Hubbell
HUBB
$27.1B
$19M 1.52%
103,330
-5,107
-5% -$958K
MET icon
17
MetLife
MET
$61.4B
$17.2M 1.38%
244,838
-10,883
-4% -$736K
UNH icon
18
UnitedHealth
UNH
$358B
$17.1M 1.37%
33,457
-2,468
-7% -$1.19M
MSFT icon
19
Microsoft
MSFT
$3.69T
$16.8M 1.35%
54,561
+14,399
+36% +$4.33M
FERG icon
20
Ferguson
FERG
$47.4B
$16.1M 1.29%
119,660
+1,131
+1% +$174K
DAC icon
21
Danaos Corp
DAC
$2.55B
$15.9M 1.27%
154,685
+60,754
+65% +$5.53M
INTU icon
22
Intuit
INTU
$98B
$14.3M 1.15%
29,802
-108
-0.4% -$55.3K
HCA icon
23
HCA Healthcare
HCA
$89.8B
$13.8M 1.11%
55,182
-2,333
-4% -$586K
ASML icon
24
ASML
ASML
$710B
$13.1M 1.05%
19,554
+4,540
+30% +$3.04M
KB icon
25
KB Financial Group
KB
$41.4B
$12.4M 0.99%
253,587
-8,036
-3% -$397K

Similar funds

Advisory Research's Q1 2022 Portfolio in Review

As of Q1 2022, Advisory Research held 463 positions worth $1.25B, down 1.8% from $1.27B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Advisory Research withdrew a net $64.1M in Q1 2022, closing 63 positions and reducing 115 holdings. Its most notable exit was EQT Corp, an estimated $59.4M position sold in full.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 31% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Advisory Research opened a new position in Ovintiv worth $34.2M.

  • Advisory Research's largest Q1 2022 buy was Ovintiv: 633,386 shares worth $34.2M.
  • Advisory Research added most to Antero Resources in Q1 2022, an estimated $14.4M increase.
  • Advisory Research's biggest Q1 2022 reduction was Coterra Energy, cutting an estimated $20.4M.
  • Advisory Research fully exited EQT Corp in Q1 2022, selling an estimated $59.4M.
  • Advisory Research's ten largest holdings make up 36% of its $1.25B portfolio in Q1 2022.
  • Advisory Research opened 112 new positions and closed 63 in Q1 2022.
  • Advisory Research's portfolio value fell 1.8% quarter-over-quarter to $1.25B.

Based on Advisory Research's 13F filing for Q1 2022, filed 16 May 2022.